Clinical Trial: Study of SNH-118110 in Advanced Solid Tumors

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649200) titled 'Study of SNH-118110 in Advanced Solid Tumors' on June 11.

Brief Summary: This is a multicenter, open-label, Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of SNH-118110 administered orally. The study consists of a dose-escalation phase and a dose-expansion phase.

Study Start Date: June 26

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: SNH-118110 Soft Capsules

Participants will continue treatment until progression of disease or the end of the study.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ScinnoHub Pharmaceutical Co., Ltd.

Published by HT Digital C...